From the Editor: Liquefaction, Dx Style
Early FDA approvals hint that the floodgates for so-called “liquid biopsy” technologies are about to be thrown wide open.
Read MoreSearch Results for: lung cancer
Inside Track: Easier Screening
The recent FDA premarket approval for the Epi ProColon colorectal cancer screening test by Epigenomics AG highlights the potential of liquid biopsy methods.
Read MoreScreening Tests That Reduce Cancer Deaths
Many tests have been shown both to find cancer early and to lower the chance of dying from the disease.
Read More
Clinical Labs and Diagnostics in Cancer Moonshot Initiatives
Advances in testing techniques are being predicted as moonshot byproducts.
Read More
Molecular Diagnostic Earns Expanded Insurance Coverage
BlueCross BlueShield of Florida and Health Care Services Corp have independently determined that the VeriStrat test from Biodesix is a medically necessary benefit.
Read More